We next decided to investigate a systemic, rather than local, treatment of MCC950 as this method has been previously described to induce sufficient NLRP3 inhibition in cases of experimental autoimmune encephalomyelitis [9]. This evidence concerns the gene NLRP3 and experimental autoimmune encephalomyelitis.